NYSE : ITGR
Integer Holdings Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 126.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.30B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.30B |
| Enterprise Value | 5.63B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 34.00M |
| Shares Outstanding | 34.00M |
| Shares Change (YoY) | -3.65% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 120.52% |
| Float | 28.90M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 42.27 |
| Forward PE | 18.69 |
| PS Ratio | 2.36 |
| Forward PS | 2.27 |
| PB Ratio | 2.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 52.60 |
| P/OCF Ratio | 24.39 |
| PEG Ratio | 2.69 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 54.33 |
| EV / Sales | 3.09 |
| EV / EBITDA | 17.69 |
| EV / EBIT | 31.45 |
| EV / FCF | 68.86 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.98 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | 16.43 |
| Interest Coverage | 4.61 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.97% |
| Return on Assets (ROA) | 3.30% |
| Return on Invested Capital (ROIC) | 5.63% |
| Return on Capital Employed (ROCE) | 5.61% |
| Weighted Average Cost of Capital (WACC) | 6.33% |
| Revenue Per Employee | $165,946 |
| Profits Per Employee | $9,427 |
| Employee Count | 11,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 5.05 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.26M |
| Effective Tax Rate | 3.95% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +93.86% |
| 50-Day Moving Average | 126.20 |
| 200-Day Moving Average | 100.81 |
| Relative Strength Index (RSI) | 62.20 |
| Average Volume (20 Days) | 793,381 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.25M |
| Short Previous Month | 2.57M |
| Short % of Shares Out | 9.56% |
| Short % of Float | 11.24% |
| Short Ratio (days to cover) | 3.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.83B |
| Gross Profit | 457.53M |
| Operating Income | 179.17M |
| Pretax Income | 107.96M |
| Net Income | 103.70M |
| EBITDA | 318.58M |
| EBIT | 179.17M |
| Earnings Per Share (EPS) | $3.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 14.14M |
| Total Debt | 1.34B |
| Net Cash | -1.33B |
| Net Cash Per Share | -$39.13 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 50.78 |
| Working Capital | 600.27M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 176.48M |
| Capital Expenditures | -94.66M |
| Depreciation & Amortization | 139.41M |
| Net Borrowing | 11.67M |
| Free Cash Flow | 81.82M |
| FCF Per Share | $2.41 |
Margins
| Measure | Value |
|---|
| Gross Margin | 25.06% |
| Operating Margin | 9.82% |
| Pretax Margin | 5.91% |
| Profit Margin | 5.68% |
| EBITDA Margin | 17.45% |
| EBIT Margin | 9.82% |
| FCF Margin | 4.48% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.65% |
| Shareholder Yield | 3.65% |
| Earnings Yield | 2.37% |
| FCF Yield | 1.90% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $127.00 |
| Price Target Difference | 0.32% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 3.14% |
| EPS Growth Forecast (3Y) | 4.79% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.51 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |